治疗性神经切除术的不良影响:对587种手术的前性研究
Iñigo Romón1, Juan Domíguez-García1, Carlos Fernández1
1Servicio de Hematología - IDIVAL, Pabellón 20, Planta Baja, Hospital Universitario Marqués de Valdecilla, Unidad de Aféresis, Santander, Spain.
在患有并发症的患者中,治疗性神经切除术 (TP) 是安全的,不良事件发生率低 (<5%). 这种程序是耐受良好,即使在老年人,当仔细管理.
科学领域:
- 医学 医学 医学 医学 医学
- 血液学 血液学 血液学
- 临床程序 临床程序
背景情况:
- 治疗性瘤切除术 (TP) 是常见的铁过载和多语言症.
- 与献血者相比,TP患者的不良事件 (AEs) 的了解较少.
- TP越来越多地用于复杂的老年人群,具有并发症.
研究的目的:
- 确定接受TP的患者中AE的发生率和性质.
- 在多样化的患者队列中评估TP的安全性.
主要方法:
- 从接受TP的患者收集前性数据.
- 结构化问卷收集了人口统计,健康状况和AE数据.
- 程序后至少24小时的后续检查.
主要成果:
- 189名患者接受了587次TP手术 (2021年8月至2022年9月).
- 10.8%的患者在4.3%的手术中经历了AEs (主要是血管血管反应).
- 所有的AE都是轻微的,由工作人员管理,完全恢复.
结论:
- 患者的TPAE很少发生 (<5%) 并与献血者可比.
- 当仔细管理时,TP对于老年患者和患有并发症的人来说是一种安全的程序.
更多相关视频
11:31Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting
Published on: November 30, 2015
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
相关概念视频
Pre-Procedural Guidelines for Assessing Blood Pressure
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Errors occurring during blood pressure monitoring
Several factors...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
